Skip to main content
Log in

Forced Degradation Studies of Sofosbuvir with a Developed and Validated RP-HPLC Method as per ICH Guidelines

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A reverse phase-high-performance liquid chromatography-diode array detector method is developed for the determination of the antiviral drug sofosbuvir in bulk and Sofos® 400 mg tablet dosage forms. Sofosbuvir is used for the treatment of chronic hepatitis C. The separation is carried out using a gradient mobile phase consisting of 0.05% H3PO4 and acetonitrile. A symmetry C18 column (4.6 × 100 mm, 2.5 µm, Waters XSELECT HSS T3) is used with a flow rate of 1.5 mL min−1 using ultraviolet detection at 260 nm with a diode array detector and an injection loop volume of 10 µL. A sharp peak is obtained at a retention time of 14 min. The method is validated appropriately according to the requirements of the United States Pharmacopeia and the International Conference on Harmonization guideline Q2 R1. System suitability, linearity, range (1.5–4.5 µg mL−1), precision, accuracy, specificity, robustness, detection and quantification limit of the method are assured. A forced degradation study of sofosbuvir is conducted under the conditions of hydrolysis, oxidation, thermal and photolysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Hassouna M, El-Kassem M, Abdelrahman M, Mohamed MA (2017) Assay and dissolution methods development and validation for simultaneous determination of sofosbuvir and ledipasvir by RP-HPLC method in tablet dosage forms. J Forensic Sci Crim Investig. https://doi.org/10.19080/JFSCI.2017.01.555562

    Article  Google Scholar 

  2. Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. https://doi.org/10.1111/j.1469-0691.2010.03432.x

    Article  PubMed  Google Scholar 

  3. ElGuennouni F (2019) Prise en charge de l’Hépatite Virale C en 2019: Place du génotypage. University of Mohamed V Rabat, Rabat

    Google Scholar 

  4. Ema Sovaldi International non-proprietary name: sofosbuvir assessment report Sovaldi. 44 (November 2013)

  5. ICH-Guideline, Stability testing of new drug substances and products Q1A(R2). Geneva

  6. Jayaprakash R, Natesan SK, Lalitha K (2017) Stability indicating RP-HPLC method development and validation for the simultaneous determination of vildagliptin and metformin in pharmaceutical dosage form. Int J Pharm Pharm Sci 9(3):150. https://doi.org/10.22159/ijpps.2017v9i3.16233

    Article  CAS  Google Scholar 

  7. Nebsen M, Elzanfaly ES (2016) Stability-indicating method and LC–MS–MS characterization of forced degradation products of sofosbuvir. J Chromatogr Sci 54(9):1631–1640. https://doi.org/10.1093/chromsci/bmw119

    Article  PubMed  CAS  Google Scholar 

  8. ICH-Guideline (2005) Validation of analytical procedures: text and methodology Q2 (R1). Geneva

  9. USP The United States Pharmacopeia 43th revision. (2020) Rockville

  10. ICH-Guideline (2006) Impurities in new drug products Q3B. London, UK

  11. ICH-Guideline (1997) Guidance for industry validation of analytical procedures: methodology Q2B. Rockville

  12. CFR (2020) Current good manufacturing practice for finished pharmaceuticals part 211, vol 4. FDA, Rockville

    Google Scholar 

  13. ICH-Guideline (1996) Photo stability testing of new drug substances and products Q1B. Geneva

Download references

Acknowledgements

The corresponding authors wish to convey his sincere thanks to BEKER Laboratories LDA team for their valuable help, support, inspiration and for providing generic products and reference standards.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Abderrazaq Hamdache.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamdache, A., Grib, L., Grib, C. et al. Forced Degradation Studies of Sofosbuvir with a Developed and Validated RP-HPLC Method as per ICH Guidelines. Chromatographia 84, 1131–1140 (2021). https://doi.org/10.1007/s10337-021-04099-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-021-04099-8

Keywords

Navigation